Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Filings indexed 227 across all filing types
Latest filing 2022-06-02 Director's Dealing
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to report insider transactions, changes in share ownership by directors, or changes in status (such as resignation) that affect shareholding. This falls under the 'Director's Dealing' category.
2022-06-02 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a significant asset acquisition (real estate for business expansion) by BioPlus Co., Ltd. While the title mentions 'merger', the content specifically describes a 'Type Asset Acquisition' (자산양수도) and confirms the final payment and completion of the transaction. Since this is a formal regulatory filing regarding a corporate transaction (M&A/Asset acquisition) that has been completed, it falls under the M&A Activity category.
2022-05-18 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Bio Plus Co., Ltd., covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including transaction methods like market purchases, stock option exercises, and conversion of convertible bonds. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of an executive (Lee Min-yeob) at Bioplus Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in executive shareholdings, which corresponds to the 'Director's Dealing' category.
2022-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to report insider transactions, such as the exercise of stock options or changes in share ownership by company directors or major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2022-05-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.